Leon O. Moulder's most recent trade in Zai Lab Limited - ADR was a trade of 10,831 American Depositary Shares done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zai Lab Limited - ADR | Leon Oliver Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 10,831 | 72,602 (0%) | 0% | 0 | American Depositary Shares | |
| Zenas Biopharma Inc. | Leon Oliver Moulder | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Zai Lab Limited - ADR | Leon O. Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 21,253 | 61,771 (0%) | 0% | 0 | American Depositary Shares | |
| Dianthus Therapeutics Inc | Leon O. Moulder | Director | 23 May 2024 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | ||
| Dianthus Therapeutics Inc | Leon O. Moulder | Director | 22 Jan 2024 | 166,667 | 1,436,745 | - | 12 | 2,000,004 | Common Stock | |
| Trevena Inc | Leon O. Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 13,700 | 13,700 | - | - | Stock Option (Right to Buy) | |
| Trevena Inc | Leon O. Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Trevena Inc | Leon O. Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 68,577 | 68,577 | - | - | Stock Option (Right to Buy) |